Tech Company Financing Transactions

Sopherion Therapeutics Funding Round

Sopherion Therapeutics closed a $55 million Series C funding round on 2/19/2009. Backers included Zoticon BioVentures, Canaan Partners and Healthcap Venture Capital.

Transaction Overview

Company Name
Sopherion Therapeutics
Announced On
2/19/2009
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series C
Investors

Zoticon BioVentures (Lead Investor) (Asher Nathan)

Canaan Partners (Seth Rudnick)

Healthcap Venture Capital

NewSpring Capital

ProQuest Investments (Joyce Tsang)

Seaflower Ventures (Alexander Moot)

Sprout Group

Proceeds Purpose
The company will use the funding to complete the pivotal Phase III clinical development program for its lead product candidate, Myocet(TM). Myocet is a liposomal formulation of doxorubicin designed to reduce the risk of cardiotoxicity while preserving antitumor efficacy.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
104 Carnegie Center 200
Princeton, NJ 08540
USA
Phone
(609) 986-2020
Website
www.sopherion.com
Email Address
[email protected]
Overview
Sopherion Therapeutics, Inc. is a biopharmaceutical company focusing on the development and commercialization of anti-cancer therapies.
Profile
Sopherion Therapeutics LinkedIn Company Profile
Social Media
Sopherion Therapeutics Company Twitter Account
Company News
Sopherion Therapeutics News
Facebook
Sopherion Therapeutics on Facebook
YouTube
Sopherion Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ronald Goldfarb
  Ronald Goldfarb LinkedIn Profile  Ronald Goldfarb Twitter Account  Ronald Goldfarb News  Ronald Goldfarb on Facebook
Executive Vice President
Marcel Rozencweig
  Marcel Rozencweig LinkedIn Profile  Marcel Rozencweig Twitter Account  Marcel Rozencweig News  Marcel Rozencweig on Facebook
VP - Finance
Alina Groblicka
  Alina Groblicka LinkedIn Profile  Alina Groblicka Twitter Account  Alina Groblicka News  Alina Groblicka on Facebook
VP - Regulatory Affairs
Salvatore Forenza
  Salvatore Forenza LinkedIn Profile  Salvatore Forenza Twitter Account  Salvatore Forenza News  Salvatore Forenza on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/19/2009: TVtrip venture capital transaction
Next: 2/20/2009: Pocket Communications Northeast venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.